Authum Investment & Infrastructure Ltd
Authum Investment & Infrastructure Limited is engaged in the business of fund-based activities viz, investment in shares, securities, mutual funds etc. and providing loans and advances, etc. [1]
- Market Cap ₹ 55,733 Cr.
- Current Price ₹ 3,285
- High / Low ₹ 3,307 / 1,326
- Stock P/E 13.6
- Book Value ₹ 861
- Dividend Yield 0.03 %
- ROCE 30.8 %
- ROE 34.1 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 209% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 33.5%
Cons
- Tax rate seems low
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5 | 43 | 317 | 222 | 351 | -36 | -11 | 256 | 907 | 374 | 2,413 | 4,568 | 4,361 | |
4 | 41 | 314 | 207 | 342 | 1 | 3 | 77 | 52 | 43 | -569 | 474 | 369 | |
Operating Profit | 1 | 2 | 3 | 14 | 10 | -37 | -13 | 178 | 856 | 331 | 2,982 | 4,095 | 3,992 |
OPM % | 20% | 5% | 1% | 6% | 3% | 70% | 94% | 88% | 124% | 90% | 92% | ||
0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -0 | 3 | 17 | 31 | 45 | |
Interest | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 21 | 30 | 46 | 76 | 46 | 58 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 6 | 5 |
Profit before tax | 0 | 1 | 1 | 14 | 9 | -37 | -15 | 157 | 826 | 287 | 2,919 | 4,074 | 3,974 |
Tax % | 33% | 0% | 20% | 38% | 32% | 0% | 0% | 14% | 19% | 16% | -0% | -4% | |
0 | 1 | 1 | 8 | 6 | -37 | -15 | 135 | 669 | 240 | 2,920 | 4,248 | 4,097 | |
EPS in Rs | 0.00 | 0.03 | 0.03 | 0.21 | 0.15 | -0.93 | -0.38 | 8.38 | 39.37 | 14.14 | 171.89 | 250.12 | 241.20 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 60% |
5 Years: | % |
3 Years: | 71% |
TTM: | 16% |
Compounded Profit Growth | |
---|---|
10 Years: | 127% |
5 Years: | 209% |
3 Years: | 85% |
TTM: | 3% |
Stock Price CAGR | |
---|---|
10 Years: | 129% |
5 Years: | 252% |
3 Years: | 138% |
1 Year: | 100% |
Return on Equity | |
---|---|
10 Years: | 32% |
5 Years: | 32% |
3 Years: | 33% |
Last Year: | 34% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 16 | 17 | 17 | 17 | 17 |
Reserves | 41 | 43 | 44 | 52 | 58 | 38 | 408 | 1,416 | 3,104 | 2,974 | 10,246 | 14,603 |
2 | 4 | 14 | 2 | 16 | 9 | 273 | 503 | 871 | 970 | 950 | 876 | |
0 | 13 | 14 | 13 | 32 | 5 | 3 | 11 | 26 | 60 | 123 | 314 | |
Total Liabilities | 55 | 71 | 84 | 79 | 118 | 63 | 695 | 1,946 | 4,019 | 4,021 | 11,337 | 15,810 |
0 | 0 | 0 | 0 | 0 | 0 | 182 | 176 | 142 | 185 | 230 | 292 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 6 |
Investments | 38 | 3 | 1 | 14 | 17 | 57 | 330 | 1,626 | 3,186 | 3,593 | 8,941 | 12,740 |
17 | 67 | 83 | 65 | 100 | 6 | 183 | 144 | 691 | 243 | 2,164 | 2,772 | |
Total Assets | 55 | 71 | 84 | 79 | 118 | 63 | 695 | 1,946 | 4,019 | 4,021 | 11,337 | 15,810 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
21 | -36 | -13 | 26 | -10 | -34 | -169 | 217 | 262 | -107 | -148 | 1,689 | |
-2 | 34 | 2 | -13 | -3 | 41 | -722 | -451 | -570 | 81 | 489 | -1,651 | |
-18 | 2 | 11 | -12 | 13 | -8 | 892 | 247 | 336 | 53 | -403 | -127 | |
Net Cash Flow | 0 | -0 | -0 | 1 | -0 | -0 | 0 | 14 | 28 | 26 | -61 | -89 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 8 | 0 | 0 | 0 | 0 | 0 | -399 | 0 | 3 | 0 | 0 | 1 |
Inventory Days | 119 | 385 | 59 | 82 | 69 | 0 | 0 | |||||
Days Payable | 0 | 116 | 16 | 18 | 34 | |||||||
Cash Conversion Cycle | 127 | 269 | 43 | 64 | 35 | 0 | -399 | 0 | 3 | 0 | 0 | 1 |
Working Capital Days | 929 | 434 | 62 | 80 | 54 | -84 | 1 | -3 | 36 | -42 | 31 | 18 |
ROCE % | 2% | 3% | 4% | 21% | 13% | -51% | -4% | 14% | 29% | 8% | 39% | 31% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Acquisition
37m - Authum to invest INR 3,000,001,553 for 3% of Serovia Pharma via Series B CCPS.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
5 Sep - Newspaper advertisement published in Business Standard and Prathakal for Agm Notice Disptach
-
Business Responsibility and Sustainability Reporting (BRSR)
4 Sep - BRSR for FY2024-25 filed Sept 4, 2025 as part of 43rd Annual Report; report link provided.
-
Weblink Letters
4 Sep - Annual Report web-link dispatched; 43rd AGM on September 26, 2025 at 4:30 PM via VC.
-
Notice Of The 43Rd Annual General Meeting
4 Sep - AGM on Sept 26, 2025 via VC; FY2024-25 Annual Report published online.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
Business Segments H1 FY25
1) Investments (89%): [1] The company invests in publicly listed and unlisted companies, private equity investments, real estate investments, and debt instruments. Also, it has been engaged in structured financing, fixed returns portfolios, secured lending, and equity investments in emerging companies. The total investments increased from 3,186 Cr in FY22 to Rs. 10,317 Cr as of Q2 FY25. [2] [3] [4] [5]